Found: 2
Select item for more details and to access through your institution.
A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03375-w
- By:
- Publication type:
- Article
Report on the Audit on Burden of Osteoporosis in Eight Countries of the Eurasian Region: Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan.
- Published in:
- Archives of Osteoporosis, 2020, v. 15, n. 1, p. N.PAG, doi. 10.1007/s11657-020-00836-y
- By:
- Publication type:
- Article